Vaccine producer Bharat Biotech International (BBIL) could begin phase
I/II human clinical trials for its single-dose intranasal vaccine
candidate for Covid-19 by the end of December or early next month, its
chairman, Krishna Ella, said on Tuesday.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotechs-intranasal-vaccine-to-enter-phase-i/ii-trials-by-month-end/articleshow/79637145.cms
No comments:
Post a Comment